Home The Active Ingredient Matrix Haematococcus pluvialis (Astaxanthin)

Formulation Intelligence

Haematococcus pluvialis (Astaxanthin)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Haematococcus pluvialis (Astaxanthin).

A potent xanthophyll carotenoid that exerts systemic antioxidant effects by spanning the phospholipid bilayer to neutralize reactive oxygen species and modulate the Nrf2/ARE signaling pathway.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

5281224

Molecular Weight

596.8 g/mol

XLogP3 (Lipophilicity)

10.3

IUPAC Name

(6S)-6-hydroxy-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4S)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-2,4,4-trimethylcyclohex-2-en-1-one

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Lutein for synergistic macular pigment density enhancement and blue light filtration
  • Phosphatidylcholine for improved cellular uptake and incorporation into mitochondrial membranes

Biological Formulation Enhancers

  • Medium-Chain Triglycerides (MCT) for enhanced micellar solubilization and lymphatic absorption
  • Piperine for inhibition of glucuronidation and increased systemic bioavailability

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Haematococcus pluvialis (Astaxanthin) across standard consumer modalities.

💊 Standard Capsules

Astaxanthin is highly susceptible to photo-oxidation and thermal degradation, requiring nitrogen-flushed softgels or airtight encapsulation to maintain potency.

🍬 Gummy & Pectin Formats

The intense pigment of astaxanthin causes significant staining of manufacturing equipment and may lead to color instability or leaching in pectin-based matrices.

🔬 Thin-Film Oral Strips

The high lipophilicity and required therapeutic dosage of astaxanthin often exceed the payload capacity of thin-film polymers, complicating uniform dispersion.

For Brand Founders

Formulate with Haematococcus pluvialis (Astaxanthin)

Ready to launch a product featuring Haematococcus pluvialis (Astaxanthin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Haematococcus pluvialis (Astaxanthin) Bioavailability

Need absolute proof that your Haematococcus pluvialis (Astaxanthin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Haematococcus pluvialis (Astaxanthin) Degradation Testing

Is your Haematococcus pluvialis (Astaxanthin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation